Structure Gene, mRNA, and mRNA Synthesis and release Inhibitors Biological functions Clinical implications
ChemicalBook > CAS DataBase List > EC 3.4.15.1

EC 3.4.15.1

Structure Gene, mRNA, and mRNA Synthesis and release Inhibitors Biological functions Clinical implications
Product Name
EC 3.4.15.1
CAS No.
9015-82-1
Chemical Name
EC 3.4.15.1
Synonyms
ACE;ANGIOTENSIN CONVERTING ENZYME;ACE (HUMAN);EC 3.4.15.1;ACE (enzyme);Carboxycathepsin;Carboxypeptidase Zace2;PEPTIDYLDIPEPTIDE HYDROLASE;ACE, Peptidyl-dipeptidaseA;Angiotens Converting Enzyme
CBNumber
CB3358160
Molecular Formula
C2H5NO
Formula Weight
59.0672
MOL File
9015-82-1.mol
More
Less

EC 3.4.15.1 Property

storage temp. 
-20°C
form 
lyophilized powder
color 
Off-white to light yellow
Specific Activity
≥2.0units/mg protein (modified Warburg-Christian)
More
Less

Safety

WGK Germany 
3
10-21
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H334May cause allergy or asthma symptoms or breathing difficulties if inhaled

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P284Wear respiratory protection.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
A6778
Product name
Angiotensin Converting Enzyme from rabbit lung
Purity
≥2.0?units/mg protein (modified Warburg-Christian)
Packaging
0.1unit
Price
$97.9
Updated
2024/03/01
Sigma-Aldrich
Product number
A6778
Product name
Angiotensin Converting Enzyme from rabbit lung
Purity
≥2.0?units/mg protein (modified Warburg-Christian)
Packaging
0.25unit
Price
$181
Updated
2024/03/01
Sigma-Aldrich
Product number
A6778
Product name
Angiotensin Converting Enzyme from rabbit lung
Purity
≥2.0?units/mg protein (modified Warburg-Christian)
Packaging
1unit
Price
$506
Updated
2024/03/01
Sigma-Aldrich
Product number
A6778
Product name
Angiotensin Converting Enzyme from rabbit lung
Purity
≥2.0?units/mg protein (modified Warburg-Christian)
Packaging
2units
Price
$956
Updated
2024/03/01
Sigma-Aldrich
Product number
A6778
Product name
Angiotensin Converting Enzyme from rabbit lung
Purity
≥2.0?units/mg protein (modified Warburg-Christian)
Packaging
5units
Price
$2040
Updated
2024/03/01
More
Less

EC 3.4.15.1 Chemical Properties,Usage,Production

Structure

Two isozymes of ACE are present in mammals: somatic ACE and testis ACE. Somatic ACE possesses two catalytic domains (N- and C-domains) and a C-terminal transmembrane segment (stalk). Both catalytic domains are zinc-metallopeptidase with the active motif HEMGH where the two histidine residues coordinate the zinc ion. The Km for Hip-His-Leu is 2.51mM. The stalk anchors the enzyme on the membrane and is suspectible to be cleaved by shedding enzymes, resulting in plasma ACE activity. ACE2 is a chimera protein with a single catalytic domain of ACE, and a C-terminal that highly resembles collectrin, which may act as a chaperone protein to deliver other proteins to the brush border membrane. Somatic and testis ACEs in humans contain 1306 and 665 aa residues, respectively. The testis ACE only possesses one catalytic domain.

Gene, mRNA, and mRNA

The ACE and ACE2 genes are located at chromosomes 17q23 and Xp22 in humans, respectively. The testis ACE is transcribed from the same gene with an alternative transcription starting site on the 13th intron of ACE, resulting in only a C-domain and a stalk segment with a unique additional 67 aa N-terminal sequence in humans. The two catalytic domains are the result of gene/domain duplication. The duplication occurred multiple times in evolution as the cnidarians, crustaceans, insects, and vertebrates possess ACE-like enzymes with one or two catalytic domains. No expression studies so far have been performed for nonmammalian ACE and ACE2. 

Synthesis and release

The expression of ACE is affected by steroids and the thyroid hormone, but the details of the regulation are not clear. ACE is under promoter regulation by hypoxiainducing factor 1α (HIF-1α), which upregulates the ACE expression under hypoxic conditions, resulting in an increase in Ang II concentration. Under hypoxia, ACE2 will be downregulated; it was shown that it is indirectly controlled by Ang II, but not HIF-1α.  Testis ACE expression control is highly specific and regulated by a tissue-specific promoter located immediately -59 bp of the transcription start site, which is frequently used in testis-specific overexpression studies. Hypoxia induced by high temperature decreased the gill ACE activity but had no effect on the kidney in the carp. Promoters of ACE2 from mammals, amphibians, and teleosts drive specific expression in the heart. Cis-Element search results discovered WGATAR motifs in all putative ACE2 promoters from different vertebrates, suggesting a possible role of GATA family transcriptional factors in ACE2 expression regulation.

Inhibitors

The first ACE inhibitor was a peptide antagonist called SQ 20,881 (GWPRPEIPP); it was discovered from snake venom but was not orally active. The snake venom peptides were further studied to produce the first orally active form, captopril, which lowers the blood pressure of essential hypertensive patients. The most common side effects of captopril are a cough, skin rash, and loss of taste. Therefore, derivatives such as enalapril, lisinopril, and ramipril were developed with fewer side effects. After the discovery of the N- and C-domains of ACE, specific domain inhibitors were developed to increase specificity. Ang I is mainly hydrolyzed by the C-domain in vivo, but BK is hydrolyzed by both domains. Developing a C-domain selective inhibitor (RXPA380) would permit some degradation of BK by the N-domain; this degradation could be enough to prevent the accumulation of excess BK causing angioedema.

Biological functions

The well-known function of ACE is the conversion of Ang I to Ang II and the degradation of BK, which plays an important role in controlling the blood pressure. ACE also acts on other natural substrates, including encephalin, neurotensin, and substance P. Besides being involved in blood pressure control, ACE possesses widespread functions including renal development, male fertility, hematopoiesis, erythropoiesis, myelopoiesis, and immune responses. ACE2 can convert Ang II to Ang1–7, thereby reducing the concentration of Ang II and increasing that of Ang1–7. ACE2 can also convert Ang I to Ang1–9, which is subsequently converted into Ang1–7 by ACE. The high expression of ACE2 favors the balance of Ang1–7 over Ang II, which accounts for the cardioprotective role of ACE2 via the Ang1–7/Mas signaling pathway.

Clinical implications

The inclusion (II) or deletion (DD) of the 287 bp Alu repeat in the 16th intron affects the human plasma ACE levels. The DD genotype is more frequently found in patients with myocardial infarction but no convincing evidence is available on the association of the DD genotype with hypertension. ACE2 was identified as the receptor for the SARS (severe acute respiratory syndrome) coronavirus. The SARS virus binding downregulates the cellular expression of ACE2, and the binding induces the clathrin-dependent internalization of the virus/receptor (SARS/ACE2) complex. Not only has ACE2 facilitated the invasion of the SARS virus for rapid replication, but also ACE2 is depleted from the cell membrane. Therefore, the damaging effects of Ang II are enhanced, resulting in the acute deterioration of lung tissues.

Description

ACE possesses dual actions to convert Ang I to Ang II, and degrade bradykinin. The development of an ACE inhibitor was the first effective drug for hypertension caused by high renin activity. ACE2 was identified as the receptor for the SARS (severe acute respiratory syndrome) coronavirus, which caused an epidemic in 2002–2003. ACE was discovered in the mid-1950s through the observation that the dialysis of plasma and kidney extract with water and saline before incubation produced two separate pressor substances, Ang I and Ang II, respectively. It was discovered for a second time in 1966 during the characterization of a bradykinin (BK)-degrading enzyme from the kidney. This was named kininase II, which later was found to be the same enzyme as ACE. ACE2 was discovered in 2000 when two independent research groups cloned homologous ACE that could convert Ang I to Ang1–9 and yet also be captopril-insensitive.

Uses

Angiotensin converting enzyme from rabbit lung has been used:

  • for measuring inhibitory effect of egg white protein hydrolysates on ACE activity by high performance liquid chromatography (HPLC)
  • to measure the ACE inhibition by litchi pericarp and cooked chicken breast using hippuryl-L-histidyl-L-leucine (HHL) as substrate by reverse phase-HPLC (RP-HPLC)3 and HPLC respectively
  • in releasing GPI anchored protein in vitro in few cell lines like HeLa, HEK293 and in vivo in mice sperm.

General Description

The angiotensin-converting enzyme (ACE) is a dipeptidyl-carboxypeptidase which exists in somatic and testicular isoforms with zinc binding motif HEXXH in their active site. ACE regulates blood pressure through renin-angiotensin system. ACE elevates blood pressure by converting angiotensin I to a key vasoconstrictor angiotensin II and inhibiting a potent vasodilator bradykinin. Inhibition of ACE is a targeted therapeutic strategy for high blood pressure. Several ACE synthetic inhibitory peptides available for clinical use include captopril, enalapril and lisinopril. Currently, developing inhibitory peptides from natural food sources, or phenolic compounds from plant sources to inhibit ACE is underway. ACE plays a critical role in fertilization by releasing the proteins anchored to glycosylphosphatidylinositol (GPI) in sperm membrane.

Biochem/physiol Actions

Removes C-terminal dipeptides from susceptible substrates, e.g., angiotensin I and bradykinin.

Clinical Use

ACE has been the target of hypertension control since the 1970s. ACE inhibitors are prescribed as the sole or combinational treatment for high blood pressure, for its dual effects of lowering Ang II and slowing down BK degradation. In human hypertensive patients, ACE2 levels are lower in both the kidney and heart compared to normotensive volunteers.

Purification Methods

Purify ACE by fractionation on DEAE-cellulose, Ca phosphate gel chromatography, elution from Sephadex G-200 and lectin affinity chromatography. The MW varied with glycosidation and is higher by gel filtration. It contains one atom of Zn/mol and has Km values for hydrolysis of hippurylhistidinylleucine and angiotensin I of 2.3 and 0.07 mM, and turnover of 15,430 and 792 mol/min/mol at 37o, respectively. The activity is inhibited by EDTA and increased amounts of Ca ions but required Ca ions. [Das & Soffer J Biol Chem 250 6762 1975, Reviewed by Ehlers & Riordan Biochemistry 28 5311 1989.]

EC 3.4.15.1 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

EC 3.4.15.1 Suppliers

Shanghai Yingxin Laboratory Equipment Co., Ltd.
Tel
021-021-59178156 17002132182
Email
3146474380@qq.com
Country
China
ProdList
11603
Advantage
58
Shanghai Guchen Biotechnology Co., LTD
Tel
021-34675735 19147740836
Email
1986399151@qq.com
Country
China
ProdList
9844
Advantage
58
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15839
Advantage
69
Sinopharm Chemical Reagent Co,Ltd.
Tel
86-21-63210123
Fax
86-21-63290778 86-21-63218885
Email
sj_scrc@sinopharm.com
Country
China
ProdList
9815
Advantage
79
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com
Country
China
ProdList
4554
Advantage
62
ShangHai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847 13636370518
Fax
021-55068248
Email
shyysw007@163.com
Country
China
ProdList
4940
Advantage
60
Shanghai BeiZhuo Biotech Co., Ltd.
Tel
021-61119791,13386096464
Fax
021-50190009
Email
bzswkf@foxmail.com
Country
China
ProdList
3921
Advantage
50
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939 15221275939
Fax
021-50706099
Email
shenlinxing@macklin.cn
Country
China
ProdList
16166
Advantage
55
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Beijing NuoqiYa Biotechnology Co., Ltd.
Tel
4000-819-385 010-62329685 13718666987
Fax
010-62340519
Country
China
ProdList
1971
Advantage
55
Raw material medicin reagent co.,Ltd
Tel
Email
sales@njromanme.com
Country
China
ProdList
4529
Advantage
58
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 4009686088
Email
3193328036@qq.com
Country
China
ProdList
29764
Advantage
68
Shanghai Yihe Biological Technology Co., Ltd.
Tel
17721395025
Fax
021-68882955
Email
2423903095@qq.com
Country
China
ProdList
4143
Advantage
58
Guangzhou LES biological Technology Co.,Ltd.
Tel
13672434928
Fax
-
Email
3307355104@qq.com
Country
China
ProdList
3650
Advantage
58
Shenzhen Regent Biochemical Technology Co., Ltd.
Tel
0755-0755-85201366 18938635012
Fax
0755-85201366
Email
sales@regentsciences.com
Country
China
ProdList
9589
Advantage
58
Tianjin heowns Biochemical Technology Co., Ltd.
Tel
400-6387771-6037 18920794737
Email
sales@heowns.com
Country
China
ProdList
23083
Advantage
60
Beijing OKA biological technology co., LTD
Tel
010-010-010-62971590 18548936886
Fax
010-62340519
Email
jack@oka-vip.com
Country
China
ProdList
6897
Advantage
58
Hefei Bomei Biotechnology Co., Ltd.
Tel
13739298932
Email
531626407@qq.com
Country
China
ProdList
3004
Advantage
58
Guangzhou Tomums Life Science Co., Ltd.
Tel
020-31155029 18902330969
Fax
020-31155029
Email
sales@tomums.cn
Country
China
ProdList
4696
Advantage
58
Henan Alfa Chemical Co., Ltd
Tel
Country
China
ProdList
12341
Advantage
58
Career Henan Chemica Co
Tel
+86-0371-86658258 +8613203830695
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30233
Advantage
58
Shanghai Hongshun Biological Technology Co., Ltd.
Tel
15901914505 15901914505
Fax
021-54389085
Email
3187892335@qq.com
Country
China
ProdList
9092
Advantage
58
wuhan dingxingtong Chemical Technology Co., Ltd Co., Ltd
Tel
027-59207796 13429867250
Fax
027-59207796
Email
w13429867250@163.com
Country
China
ProdList
1999
Advantage
58
Shanghai jingkang bioengineering co., ltd.
Tel
021-54721350 13524668266
Fax
021-5
Email
2881505714@qq.com
Country
China
ProdList
7872
Advantage
58
Shanghai Kanglang Biotechnology Co., Ltd.
Tel
021-61998208 18217752821
Fax
021-37680378
Email
sales@klbio.cn
Country
China
ProdList
9618
Advantage
58
Shanghai Sig Biotechnology Co., LTD
Tel
021-57810052 18930344717
Fax
021-57810052
Email
2089316240@qq.com
Country
China
ProdList
9395
Advantage
58
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Fax
QQ:422450190
Email
422450190@qq.com
Country
China
ProdList
10357
Advantage
58
Wuhan Yanzhe Technology Co., Ltd
Tel
15527250409
Fax
QQ:2692360204
Email
wenhaotian12@163.com
Country
China
ProdList
4169
Advantage
58
Lingyuan Bebiansen Biological Technology Co., Ltd
Tel
18642120371
Email
2837458851@qq.com
Country
China
ProdList
7995
Advantage
58
Hubei Zhonglong Kangsheng fine chemical Co.,Ltd
Tel
027-83850299 15827297403
Fax
Q2315383731
Email
2315383731@qq.com
Country
China
ProdList
4273
Advantage
58
Shaanxi Dideu Medichem Co. Ltd
Tel
029-029-81124267 15229202216
Fax
029-88380327
Email
1073@dideu.com
Country
China
ProdList
9936
Advantage
58
Foshan Treasure Biotechnology Co., Ltd
Tel
0757-85921206 18520245316
Email
2329783215@qq.com
Country
China
ProdList
12661
Advantage
58
Nantong Feiyu Biological Technology CO.,LTD
Tel
0513-68819626; 15152877458
Fax
0513-68669626
Email
feiyubio@163.com
Country
China
ProdList
4819
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59102966 18717199209
Fax
027-59379337
Email
2853877583@qq.com
Country
China
ProdList
3000
Advantage
58
Shanghai Boer Chemical Reagent Co., LTD
Tel
19102157732
Email
zhangmin@boerchina.net
Country
China
ProdList
7849
Advantage
58
Shanghai Yaji Biological Technology Co., Ltd.
Tel
021-34661275 15301693058
Email
yajikit@163.com
Country
China
ProdList
9720
Advantage
58
JiangSu Star Science Co.,Ltd
Tel
400-400-605-7200-7200 15335295587
Email
sales037@b2star.com
Country
China
ProdList
3761
Advantage
58
Hubei Weideli Chemical Reagent Co.,Ltd.
Tel
13339985473
Email
C13339985473@163.com
Country
China
ProdList
4403
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24644
Advantage
58
Shanghai klamar Reagent Co., LTD
Tel
4001650900 13817534909
Email
3003940895@qq.com
Country
China
ProdList
10717
Advantage
58
Shanghai Huzhen Industrial Co., LTD
Tel
021-60345367 13916550749
Email
sales@shzbio.com
Country
China
ProdList
9966
Advantage
58
Shanghai Lebeishi Biotechnology Co., LTD
Tel
13774214275
Email
labex-mkt@univ-bio.com
Country
China
ProdList
5512
Advantage
58
Shanghai Yingxin laboratory equipment Co., Ltd
Tel
021-021-59178156 15300768757
Email
359382369@qq.com
Country
China
ProdList
10674
Advantage
58
G-CLONE
Tel
400-910-1997 17560619001
Email
3243204476@qq.com
Country
China
ProdList
9959
Advantage
58
Shandong Mopai Biotechnology Co., Ltd
Tel
13070690626
Email
admin@mopaikeji.com
Country
China
ProdList
3801
Advantage
58
Beijing Boorsen Biotechnology Co., Ltd
Tel
400-901-9800 18611424007
Email
cis@bioss.com.cn
Country
China
ProdList
9518
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59102966 18717199209
Email
2853877583@QQ.com
Country
China
ProdList
7885
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd.
Tel
025-66061636 18013972705
Email
qqyang@aikonchem.com
Country
China
ProdList
10238
Advantage
58
microBioSyn Biotech Co,. Ltd.
Tel
153-0048-7802 15300487802
Email
jlin@microbiosyn.com
Country
China
ProdList
186
Advantage
58
Shanghai Zheyan Biotech Co., Ltd.
Tel
021-18017610038 18017610038
Email
897493074@qq.com
Country
China
ProdList
4997
Advantage
58

9015-82-1, EC 3.4.15.1Related Search:


  • PEPTIDYLDIPEPTIDE HYDROLASE
  • ANGIOTENSIN CONVERTING ENZYME FROMRABBIT LUNG
  • ANGIOTENSIN-CONVERTIN-GAMMA-ENZYME
  • ANGIOTENSIN CONVERTING ENZYME
  • ANGIOTENSIN CONVERTING ENZYME (HUMAN)
  • ACE
  • ACE (HUMAN)
  • ACE (enzyme)
  • Angiotensin converting enzyme 1
  • Angiotensin I-converting enzyme
  • Angiotensin-1 converting enzyme
  • Angiotensin-converting enzyme I
  • Angiotension-converting enzyme
  • Carboxycathepsin
  • Carboxypeptidase Zace2
  • Dipeptidyl carboxypeptidase A
  • Dipeptidyl carboxypeptidase I
  • Dipeptidyl serine carboxypeptidase
  • ANGIOTENSIN CONVERTING ENZYME FROMPORCIN E KIDNEY
  • ANGIOTENSIN-CONVERTING-ENZYME F. RABBIT LUNG, ~3 U/MG
  • ACE, Peptidyl-dipeptidaseA, Peptidyldipeptide Hydrolase
  • ACE, Peptidyl-dipeptidaseA
  • Angiotensin Converting Enzyme from porcine kidney,ACE, Peptidyl-dipeptidaseA
  • Angiotensin Converting Enzyme from rabbit lung,ACE, Peptidyl-dipeptidaseA, Peptidyldipeptide Hydrolase
  • Carboxypeptidase,dipeptidyl, A
  • EC 3.4.15.1
  • Native Rabbit Angiotensin Converting Enzyme
  • Native Rat Angiotensin Converting Enzyme
  • Native Porcine Angiotensin Converting Enzyme
  • Recombinant Human CD143/ACE Protein, His Tag
  • Angiotens Converting Enzyme
  • 9015-82-1
  • BioChemical
  • Biochemicals and Reagents
  • Proteolytic Enzymes
  • Proteolytic Enzymes and Substrates
  • Enzymes, Inhibitors, and Substrates